How would pharmaceutical companies react to the EAL? Don they have a valid concern about parallel importing?
Pharmaceutical companies will have probably voice a concern over parallel importing (low-priced generics produced under the EAL finding their way into the black market in developed countries), but is this concern valid? Not really. New regulatory barriers and customs regulations have minimized the threat of this, so the idea is being used more as a political excuse than as a practical concern. This concern finds little empirical support, and can be addressed in the same manner that the WTO has elected to treat the issue: requiring use of different packaging, pill color, and shape in different countries to facilitate identification ofillegal importations.
Related Questions
- If a speakers relationships with pharmaceutical and equipment companies change during the course of the year, must she complete another financial disclosure form?
- General Product Related Questions Q - 11. Do WaterOz minerals react with pharmaceutical medications?
- Why do pharmaceutical companies seldom give medicines to poor people?
